Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1760772

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1760772

Hemoglobin A1C (HbA1C) Testing

PUBLISHED:
PAGES: 511 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Hemoglobin A1C (HbA1C) Testing Market to Reach US$2.3 Billion by 2030

The global market for Hemoglobin A1C (HbA1C) Testing estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$915.7 Million by the end of the analysis period. Growth in the Immunoassays segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$422.0 Million While China is Forecast to Grow at 10.6% CAGR

The Hemoglobin A1C (HbA1C) Testing market in the U.S. is estimated at US$422.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$274.2 Million by the year 2030 trailing a CAGR of 10.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 8.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR.

Global Hemoglobin A1C (HbA1c) Testing Market - Key Trends & Drivers Summarized

Hemoglobin A1C (HbA1c) testing is a crucial diagnostic tool for managing diabetes, providing a long-term indicator of blood glucose levels over the past two to three months. Unlike regular blood glucose tests that measure a snapshot of current blood sugar levels, HbA1c tests reflect the average blood glucose levels by measuring the percentage of glycated hemoglobin in the blood. This test is essential for diagnosing diabetes, assessing the effectiveness of treatment plans, and making necessary adjustments to medication or lifestyle. It helps healthcare providers and patients monitor glycemic control more effectively, thereby reducing the risk of diabetes-related complications.

The importance of HbA1c testing in diabetes management cannot be overstated, as it provides comprehensive insights into how well a patient's blood sugar levels are being managed over time. The test is typically recommended every three to six months for individuals with diabetes, but it is also used for screening and diagnosing prediabetes and diabetes in the general population. Advances in testing technology have made HbA1c tests more accurate, accessible, and convenient, with point-of-care testing devices enabling quicker results in clinical settings. Additionally, home testing kits have become available, empowering patients to monitor their condition more proactively.

The growth in the Hemoglobin A1C (HbA1c) testing market is driven by several factors. Firstly, the rising prevalence of diabetes worldwide is increasing the demand for regular HbA1c testing to manage and diagnose the condition effectively. Secondly, advancements in diagnostic technology are making HbA1c tests more accurate and accessible, enhancing their adoption in both clinical and home settings. Thirdly, the growing emphasis on preventive healthcare and early diagnosis of diabetes is driving the market for HbA1c testing as a key component of diabetes management programs. Lastly, increasing awareness and education about diabetes and its complications are encouraging more frequent and consistent testing among at-risk populations. These factors collectively ensure the continued growth and importance of the HbA1c testing market.

SCOPE OF STUDY:

The report analyzes the Hemoglobin A1C (HbA1C) Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays, Other Technologies); End-Use (Hospitals & Clinics, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 110 Featured) -

  • Abbott Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • A. Menarini Diagnostics Srl
  • Apex Biotechnology Corporation
  • Axis-Shield Diagnostics Ltd.
  • Agappe Diagnostics Ltd.
  • Biorex Diagnostics
  • Boditech Med, Inc.
  • Biosurfit SA
  • Accruex Biomedical Pvt., Ltd.
  • Ailex Technology Group Co., Ltd.
  • American Screening Corporation, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP-1218

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Tariff Impact on Global Supply Chain Patterns
    • Competition
    • Hemoglobin A1C (HbA1C) Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • HbA1c Devices: Critical Role in Monitoring & Management of Diabetes
    • Role of HbA1c Testing in Diabetes Diagnosis and Management
    • Interpretation of HbA1c in NGSP and IFCC Units as per the American Diabetes Association
    • Global Market Analysis and Prospects
    • World Hemoglobin A1C (HBA1C) Testing Market Set to Witness Rapid Growth
    • While Developed Regions Lead, Asia-Pacific to Spearhead Long-term Growth
    • Chromatography-based Hb Testing Devices Lead Market
    • Ion-Exchange HPLC Test for Hemoglobin A1c Makes Notable Headway as Reliable Diabetes Screening Tool
    • HPLC Testing for HbA1c Retains Value as Gold Standard
    • Ion-exchange HPLC Testing: Primary Merits for Different Stakeholders
    • HbA1c Testing to Witness Skyrocketing Interest with Focus on POC Testing for Diabetes
    • Diabetes Screening to Receive Special Thrust from Rapid Point-Of-Care HbA1c Testing
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Diabetes Prevalence and the Need for Diabetes Management to Prop-up Demand for HbA1c Monitoring Devices
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
    • World Diabetes Prevalence (2000-2045P)
    • Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
    • Diabetes Emerges as One of the Leading Causes of Mortality
    • Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
    • Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
    • Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
    • Point-of-Care (POC) HbA1c Testing Products/Analyzers of Select Players
    • Laboratory-based HbA1c Testing Products/Analyzers of Select Players
    • Major Testing Methods in POC HbA1c Tests
    • High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Increasing Obesity Levels Underpins Market Growth
    • Average Per Capita Annual Health Expenditure (In US$) due to Obesity
    • Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Increasing Healthcare Expenditure Fuels Demand for HbA1c Testing Devices
    • Variants & Derivatives Affecting Accuracy of HbA1c Testing
    • Rising Menace of Undiagnosed Diabetes Turns Heads towards Hemoglobin A1c Testing
    • Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
    • Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Hemoglobin A1C Testing
    • Technology Developments Transform Diagnostics in Diabetes Care
    • Non-Invasive Glucose Meters and Continuous Glucose Monitors Offer Viable Alternative to Hemoglobin A1c Monitoring
    • Role of Hemoglobin A1C Monitoring in Patients with Chronic Kidney Disease
    • HbA1C Testing Holds Significance as Screening Strategy for Gestational Diabetes
    • Home HbA1C Testing Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hemoglobin A1C (HbA1C) Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Boronate Affinity Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Direct Enzymatic Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Market Facts & Figures
    • US Hemoglobin A1C (HbA1C) Testing Market Share (in %) by Company: 2022 & 2030
    • Ion-Exchange High Performance Liquid Chromatography (HPLC) (Technology) Market Share Analysis (in %) of Leading Players in the US for 2022 & 2030
    • Immunoassays (Technology) Competitor Revenue Share (in %) in the US: 2022 & 2030
    • Boronate Affinity Chromatography (Technology) Market Share Breakdown (in %) of Major Players in the US: 2022 & 2030
    • Direct Enzymatic Assays (Technology) Market in the US: Percentage Breakdown of Revenues by Company for 2022 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • TABLE 47: China Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Market Facts & Figures
    • European Hemoglobin A1C (HbA1C) Testing Market: Competitor Market Share Scenario (in %) for 2022 & 2030
    • Ion-Exchange High Performance Liquid Chromatography (HPLC) (Technology) Market Share (in %) by Company in Europe: 2022 & 2030
    • Immunoassays (Technology) Market Share (in %) of Major Players in Europe: 2022 & 2030
    • Boronate Affinity Chromatography (Technology) Competitor Market Share Analysis (in %) in Europe: 2022 & 2030
    • Direct Enzymatic Assays (Technology) Market in Europe: Competitor Revenue Share Shift (in %) for 2022 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • TABLE 62: France Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • TABLE 119: India Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!